Shots:Vara has received the European CE Mark approval for its breast imaging AI to operate as an independent second reader for both screening & diagnostic use, with EU availability starting Oct 15, 2025Breast imaging AI was evaluated in the PRAIM study of 460,000 women across Germany, which demonstrated significant improvements in cancer detection &…
There are tons of clinical trials taking place at this moment. It’s a nasty disease and it’s important to figure out different ways to diagnose it, treat it, and, if possible, prevent it. 2024 brings on innovations in this field.It can probably shed light on how cancer can become more treatable and not such…
Shots: Exemplifying awareness campaign at its best with a hint of contemporary music, “It takes 2” by Boehringer Ingelheim and Eli Lilly is a noble initiative aimed at integrating UACR testing with eGFR for better screening of CKD Noelle Bush, in an engaging conversation with PharmaShots, cites the growing incidences of CKD in the US.…
Shots:Martin gave a detailed view of the newly launched Honey Analytics module associated with the Trialbee Honey™ platformHe also talked about the how Trialbee Honey platform will help in the screening and recruiting of patients specifically in remote areasThe interview gives a profound understanding of how Trialbee is developing real-time monitoring modules…

